COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Rexahn Phase 2a Combination Study of RX-3117 and Abraxane® in First-line Metastatic Pancreatic Cancer Patients Advances to Second Stage15/05/2018
-   
  MimiVax to Present Interim Phase II Trial Data on Multi-focal Immunotherapy SurVaxM for the Treatment of Glioblastoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting15/05/2018
-   
  CRISPR Therapeutics Announces Presentations at the ASGCT 21st Annual Meeting15/05/2018
-   
  UroGen Pharma Reports First Quarter 2018 Financial Results and Recent Corporate Developments15/05/2018
-   
  Adherium to Present at the Chardan Digital Health Conference on Tuesday, May 22, 201815/05/2018
-   
  Interpace Diagnostics Group Reports First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments15/05/2018
-   
  Inovio HIV Vaccine, Which Generated Near 100% Immune Responses, Sustained Durable Memory Responses Measured One Year After The Start of Clinical Trial15/05/2018
-   
  Progressive Care Inc. Reports Largest Single Revenue Quarter in Company History15/05/2018
-   
  Emerald Health Therapeutics Announces $16.8 Million Prospectus Sale; Concurrent Secondary Sale15/05/2018
-   
  Arch Therapeutics to Provide Corporate Update at the 8th LD Micro Invitational on Monday, June 4, 201815/05/2018
-   
  Affimed Reports Financial Results for First Quarter 201815/05/2018
-   
  Trading by management and close relations of management15/05/2018
-   
  Cannabis Wheaton Income Corp. Provides FV Pharma Inc. Facility Development Update15/05/2018
-   
  Cutera to Present at Jefferies Global Healthcare Conference15/05/2018
-   
  Myriad Genetics to Present Eight Studies at the 2018 American Society of Clinical Oncology Annual Meeting15/05/2018
-   
  XOMA to Present at the UBS Global Healthcare Conference15/05/2018
-   
  Bellicum Announces Oral Presentation on Dual-Switch CAR-T Technology at the 21st Annual Meeting of the American Society of Gene and Cell Therapy15/05/2018
-   
  Cancer Genetics Reports First Quarter 2018 Financial Results and Provides Strategic Business Updates15/05/2018
-   
  Xenon Presents Positive XEN1101 TMS Pharmacodynamic Phase 1 Data at 14th Eilat Conference15/05/2018
Pages